<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02820610</url>
  </required_header>
  <id_info>
    <org_study_id>SM62016</org_study_id>
    <nct_id>NCT02820610</nct_id>
  </id_info>
  <brief_title>Analgesia After Pediatric Laparoscopy</brief_title>
  <official_title>Intraperitoneal Instillation of Dexmedetomidine Versus Magnesium Sulfate in Children Undergoing Laparoscopic Herniorrhaphy: a Randomized Clinical Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is important to keep children undergoing laparoscopic surgery pain free with rapid return
      to normal activity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pain following laparoscopy is less intense than after laparotomy. Nevertheless, laparoscopy
      is not pain free and control of post-laparoscopy pain remains a major concern. The exact
      cause of such pain remains uncertain, and yet, diaphragmatic irritation and peritoneal
      stretching associated with gas insufflation may be responsible for shoulder and diffuse
      abdominal pain.

      additionally poor pain control could limit the activity of children following laparoscopic
      surgery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2016</start_date>
  <completion_date type="Actual">February 2018</completion_date>
  <primary_completion_date type="Actual">February 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>24 hr</time_frame>
    <description>The Face Legs Activity Cry and Consolability (FLACC) pain score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the functional recovery</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>the functional activity score (FAS)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Analgesia</condition>
  <arm_group>
    <arm_group_label>Dexmedetomidine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 ug/kg of dexamedetomidine will instilled into the peritoneal cavity</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Magnesium sulfate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>50 mg/kg of magnesium sulfate will instilled into the peritoneal cavity</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>10 ml of normal saline 0.9 % will instilled into the peritoneal cavity.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>1 ug/kg of dexamedetomidine will instilled into the peritoneal cavity</description>
    <arm_group_label>Dexmedetomidine</arm_group_label>
    <other_name>Presidx</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Magnesium Sulfate</intervention_name>
    <description>50 mg/kg of magnesium sulfate will instilled into the peritoneal cavity</description>
    <arm_group_label>Magnesium sulfate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline 0.9 %</intervention_name>
    <description>10 ml of normal saline 0.9 % will instilled into the peritoneal cavity.</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. age (1 to 6 years)

          2. ASA physical status I or II.

          3. scheduled for laparoscopic hernia repair under general anesthesia.

        Exclusion Criteria:

          1. Allergy to study drugs,

          2. Receiving chronic pain treatment, antiepileptic therapy or magnesium therapy,

          3. sever hepatic or renal impairment,
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Faculty of Medicine Assuit University</name>
      <address>
        <city>Asyut</city>
        <state>Assuit</state>
        <zip>71516</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 29, 2016</study_first_submitted>
  <study_first_submitted_qc>June 30, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 1, 2016</study_first_posted>
  <last_update_submitted>March 23, 2018</last_update_submitted>
  <last_update_submitted_qc>March 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Seham Mohamed Moeen Ibrahim</investigator_full_name>
    <investigator_title>lecturer</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Magnesium Sulfate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

